Skip to main content
OpenTrials

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,636 public trials 301 recruiting studies
Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Recruiting

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

NCT07473778

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UAB 1917 Research Clinic Birmingham, Alabama, United States
  • Pacific Oaks Medical Group Beverly Hills, California, United States
  • Ruane Clinical Research Group Inc. Los Angeles, California, United States
  • Family Health Centers of San Diego San Diego, California, United States
View all 31 locations
View Trial Details
Recruiting

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

NCT07682961

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • CAN Community Health Fort Lauderdale Fort Lauderdale, Florida, United States
  • Midway Immunology and Research Center Ft. Pierce, Florida, United States
  • Be Well Medical Center Berkley, Michigan, United States
View Trial Details
Recruiting

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

NCT02140255

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • 4601, University of California, San Diego Clinical Research Site La Jolla, California, United States
  • 5048, University of Southern California Clinical Research Site Los Angeles, California, United States
  • 5112, David Geffen School of Medicine at UCLA Clinical Research Site Los Angeles, California, United States
  • 5052, University of Colorado, Denver Clinical Research Site Aurora, Colorado, United States
View all 46 locations
View Trial Details
Recruiting

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

NCT07071623

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations
  • UW - KNH; Rachuonyo County Hospital ( Site 0006) Homabay County, Homa Bay County, Kenya
  • Partners in Health and Research Development (PHRD) ( Site 0002) Thika, Kiambu County, Kenya
  • KEMRI-CMR-RCTP ( Site 0003) Nairobi, Kisumu County, Kenya
  • Kargeno Research & Policy Hub ( Site 0007) Kisumu, Kenya
View all 30 locations
View Trial Details
Recruiting

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

NCT07044297

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations
  • University of Alabama at Birmingham-UAB 1917 Research Clinic ( Site 0006) Birmingham, Alabama, United States
  • USA Health University Hospitals ( Site 0020) Mobile, Alabama, United States
  • UCLA Center for Clinical AIDS Research and Education ( Site 0004) Los Angeles, California, United States
  • Bridge HIV - San Francisco Department of Public Health ( Site 0001) San Francisco, California, United States
View all 81 locations
View Trial Details

Related conditions